Moreover, to the best of our knowledge, NrCAM and NEP have never been investigated in patients with psoriasis before, and MAPT had been studied only once before, so our research may shed some new light on the association between this dermatosis and the risk of NDs or on perhaps protective role of antipsoriatic therapy in that interplay. The gene discussed is NRCAM; the disease is psoriasis.